Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
Osteosarcoma (OS) is the common primary bone cancer that affects mostly children and young adults. To augment the standard-of-care chemotherapy, we examined the possibility of protein-based therapy using mesenchymal stem cells (MSCs)-derived proteomes and OS-elevated proteins. While a conditioned me...
Main Authors: | Kexin Li, Qingji Huo, Nathan H Dimmitt, Guofan Qu, Junjie Bao, Pankita H Pandya, M Reza Saadatzadeh, Khadijeh Bijangi-Vishehsaraei, Melissa A Kacena, Karen E Pollok, Chien-Chi Lin, Bai-Yan Li, Hiroki Yokota |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2023-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/83768 |
Similar Items
-
Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes
by: Kexin Li, et al.
Published: (2023-07-01) -
Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas
by: Farinaz Barghi, et al.
Published: (2022-07-01) -
Research trends and hotspots in the immune microenvironment related to osteosarcoma and tumor cell aging: a bibliometric and visualization study
by: Wenlong Zhang, et al.
Published: (2023-11-01) -
Expression of CRT and CD47 in Gastric Carcinoma and Their Significance
by: SUN Ke, et al.
Published: (2019-01-01) -
Primary osteosarcoma of the breast
by: Hung-An Huang, et al.
Published: (2021-01-01)